Physician profile
Gregory Woods
NPI 1720073778
$5,461.78
in general payments reported to CMS, 2019-2025
27 companies · $1,299 in 2025
The $1,299 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $403 · 2020: $1,460 · 2021: $1,652 · 2022: $437 · 2023: $156 · 2024: $53.21 · 2025: $1,299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $866 · Travel and Lodging: $642.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $866.43 |
| Travel and Lodging | $642.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Orthopedics LLC | $2,339.00 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $2,048.16 | 2019-2025 | Oxford, Tapestry |
| Depuy Synthes Sales INC. | $202.99 | 2019-2020 | |
| Sanara Medtech INC. | $138.87 | 2024-2025 | Biasurge, Celleraterx |
| Pacira Therapeutics, INC. | $126.82 | 2019-2020 | |
| Bioventus LLC | $86.16 | 2020-2025 | Xcell, Exogen Ultrasound Bone Healing System |
| Vertex Pharmaceuticals Incorporated | $79.08 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $50.72 | 2019-2025 | Zilretta, Iovera, Exparel |
| Smith+Nephew, INC. | $48.49 | 2019-2020 | |
| Ethicon US, LLC | $35.15 | 2020 | |
| Abbott Laboratories | $29.98 | 2019 | |
| Moximed, INC | $28.43 | 2025 | Misha Knee System, Small, Left |
| Acera Surgical, INC. | $24.80 | 2025 | Restrata Wound Matrix |
| Heron Therapeutics, INC. | $20.31 | 2023 | Zynrelef |
| Radius Health, INC. | $19.18 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $18.46 | 2019 | |
| Vericel Corporation | $17.45 | 2021 | |
| Allergan, INC. | $16.82 | 2020 | |
| Aroa Biosurgery Incorporated | $16.58 | 2024 | |
| Avanos Medical | $16.51 | 2019 | |
| Janssen Pharmaceuticals, INC | $16.27 | 2023 | Xarelto |
| Ferring Pharmaceuticals INC. | $15.99 | 2019 | |
| Kci USA, INC. | $14.37 | 2019 | |
| Seqirus USA INC | $13.75 | 2025 | Flucelvax |
| Convatec INC. | $13.49 | 2019 | |
| Daiichi Sankyo INC. | $12.97 | 2019 | |
| Glaxosmithkline, LLC. | $10.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Woods listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.